Recursion Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

4,075,219

Value ($000)

16,668

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	16,668	0.0%	4,075,219	12/31/2025
2025 Q3	11/14/2025	20,481	0.0%	4,196,978	9/30/2025
2025 Q2	8/14/2025	23,355	0.0%	4,615,516	6/30/2025
2025 Q1	5/19/2025	33,901	0.0%	6,408,524	3/31/2025
2024 Q4	2/14/2025	15,272	0.0%	2,259,178	12/31/2024
2024 Q3	11/14/2024	14,108	0.0%	2,140,750	9/30/2024
2024 Q2	8/14/2024	15,733	0.0%	2,097,672	6/30/2024
2024 Q1	5/15/2024	2,052	0.0%	205,769	3/31/2024
2023 Q4	2/14/2024	2,237	0.0%	226,873	12/31/2023
2023 Q3	11/13/2023	1,619	0.0%	211,576	9/30/2023
2023 Q2	8/11/2023	769	0.0%	115,278	6/30/2023
2023 Q1	5/15/2023	769	0.0%	115,278	3/31/2023
2022 Q4	2/14/2023	824	0.0%	106,931	12/31/2022
2022 Q3	11/14/2022	818	0.0%	76,879	9/30/2022
2022 Q2	8/12/2022	419	0.0%	51,453	6/30/2022
2022 Q1	5/16/2022	345	0.0%	48,194	3/31/2022
2021 Q4	2/14/2022	607	0.0%	35,453	12/31/2021